Loading clinical trials...
Loading clinical trials...
The aim of this study is to evaluate the prevalence of female genital schistosomiasis (FGS) in the migrant population with gynecological problems who access our center's dedicated outpatient clinic. Furthermore, we will address the relevance of FGS in women with clinical manifestations of the upper genital tract and evaluate the role of cervical-vaginal swabs in predicting upper genital tract involvement in schistosomiasis infection. The study is classified as experimental despite its descriptive objective of the prevalence of the infection of interest, as the vaginal swab and the PCR test performed on the swab and, if necessary, on the histological sample (collected during a possible interventional procedure performed for the patient's clinical needs) are not part of the standard clinical management of these cases but will be performed for the purposes of the study.
Age
15 - 49 years
Sex
FEMALE
Healthy Volunteers
No
IRCCS Sacro Cuore Don Calabria hospital
Negrar, Verona, Italy
Start Date
February 20, 2025
Primary Completion Date
August 1, 2027
Completion Date
August 1, 2027
Last Updated
March 20, 2026
96
ESTIMATED participants
Cervical-vaginal swab
PROCEDURE
Lead Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions